Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages

Journal of Immunology

Volumn 171, Issue 9, 2003, Pages 4561-4568

  El Gayar, Stefan ^a   Thüring Nahler, Heike ^a   Pfeilschifter, Josef ^c   Röllinghoff, Martin ^a   Bogdan, Christian ^a,b,d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME REGULATION; ENZYME REPRESSION; ENZYME SUBSTRATE; FEMALE; INFLAMMATORY CELL; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 0142180008     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.9.4561     Document Type: Article

References (55)

1. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
2. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immun. 2:907.
3. Kolb, H., and V. Kolb-Bachofen. 1998. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator. Immunol. Today 19:556.
4. MacMicking, J., Q.-w. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323.
5. Bogdan, C. 2000. The function of nitric oxide in the immune system. In Handbook of Experimental Pharmacology, Vol. 143: Nitric Oxide. B. Mayer, ed. Springer, Heidelberg, p. 443.
6. Felley-Bosco, E., F. C. Bender, F. Courjault-Gautier, C. Bron, and A. F. G. Quest. 2000. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA 97:14334.
7. Musial, A., and N. T. Eissa. 2001. Inducible nitric oxide synthase is regulated by the proteasome degradation pathway. J. Biol. Chem. 276:24268.
8. Kolodziejski, P., A. Musial, J.-S. Koo, and N. T. Eissa. 2002. Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc. Natl. Acad. Sci. USA 99:12315.
9. Nicholson, B., C. K. Manner, J. Kleeman, and C. L. MacLeod. 2001. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J. Biol. Chem. 276:15881.
10. Modoleil, M., I. M. Corraliza, F. Link, G. Soler, and K. Eichmann. 1995. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 macrophages. Eur. J. Immunol. 25:1101.
11. Hey, C., J. L. Boucher, S. Vadon-LeGoff, G. Ketterer, I. Wessler, and K. Racke. 1997. Inhibition of arginase in rat and rabbit alveolar macrophages by Nw-hydroxy-D, L-indospicine: effects on L-arginine utilization by nitric oxide synthase. Br. J. Phannacol. 121:395.
12. Sonoki, T., A. Nagasaki, T. Gotoh, M. Takiguchi, M. Takeya, H. Matsuzaki, and M. Mori. 1997. Coinduction of nitric oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J. Biol. Chem. 272:3689.
13. Chang, C., J. C. Liao, and L. Kuo. 1998. Arginase modulates nitric oxide production in activated macrophages. Am. J. Physiol. 274:H342.
14. ω -hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide 3:427.
15. Doherty, T. M., R. Kastelein, S. Menon, S. Andrade, and R. L. Coffman. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151:7151.
16. Doyle, A. G., G. Herbein, L. J. Montaner, A. J. Minty, D. Caput, P. Ferrara, and S. Gordon. 1994. Interleukin 13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur. J. Immunol. 24:1441.
17. Takeda, K., M. Kamanaka, T. Tanaka, T. Kishimoto, and S. Akira. 1996. Impaired IL-13-mediated functions of macrophages in Stat6-deficient mice. J. Immunol. 157:3220.
18. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor-β, interleukin 4 and interleukin 10. Ann. NY Acad. Sci. 685:713.
19. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23.
20. Bogdan, C., Y. Vodovotz, J. Paik, Q.-w. Xie, and C. Nathan. 1994. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukocyte Biol. 55:227.
21. Bogdan, C., H. Thüring, M. Dlaska, M. Röllinghoff, and G. Weiss. 1997. Mechanism of suppression of macrophage nitric oxide release by IL-13. J. Immunol. 159:4506.
22. Munder, M., M. Eichmann, J. M. Moran, F. Centeno, G. Soler, and M. Modolell. 1999. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163:3771.
23. Rutschman, R., R. Lang, M. Hesse, J. N. Ihle, T. A. Wynn, and P. J. Murray. 2001. Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166:2173.
24. Chang, C.-I., B. Zoghi, J. C. Liao, and L. Kuo. 2000. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J. Immunol. 165:2134.
25. Stenger, S., H. Thüring, M. Röllinghoff, P. Manning, and C. Bogdan. 1995. L-N6-(1-iminoethyl)lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. Eur. J. Pharmacol. 294:703.
26. Klasen, S., R. Hammermann, M. Fuhrmann, D. Lindemann, K.-F. Beck, J. Pfeilschifter, and K. Racke. 2001. Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br. J. Pharmacol. 132:1349.
27. Corraliza, I. M., M. L. Campo, G. Soler, and M. Modolell. 1994. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174:231.
28. Sheffler, L. A., D. A. Wink, G. Melillo, and G. W. Cox. 1995. Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse expression. J. Immunol. 155:886.
29. G-monomethyl-L-arginine. Biochem. J. 316:209.
30. Connelly, L., M. Palacios-Callender, C. Ameixa, S. Moncada, and A. J. Hobbs. 2001. Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide. J. Immunol. 166:3873.
31. Louis, C. A., V. Mody, W. L. Henry, J. S. Reichner, and J. E. Albina. 1999. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am. J. Physiol. 1999:R237.
32. Morris, S. M., D. Kepka-Lenhart, and L.-C. Chen. 1998. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am. J. Physiol. 275:E740.
33. Salimuddin, A. Nagasaki, T. Gotoh, H. Isobe, and M. Mori. 1999. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am. J. Physiol. 277:E110.
34. Boucher, J. L., C. Moali, and J.-P. Tenu. 1999. Nitric oxide biosynthesis, nitric' oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell. Mol. Life Sci. 55:1015.
35. Meyer, J., N. Richter, and M. Hecker. 1997. High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo. Anal. Biochem. 247:11.
36. Albina, J. E., M. D. Caldwell, W. L. Henry, and C. D. Mills. 1989. Regulation of macrophage functions by L-arginine. J. Exp. Med. 169:1021.
37. Boutard, V., R. Havouis, B. Fouqueray, C. Philippe, J.-P. Moulinoux, and L. Baud. 1995. Transforming growth factor-β stimulates arginase activity in macrophages: implications for the regulation of macrophage cytotoxicity. J. Immunol. 155:2077.
38. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167:6533.
39. Granger, D. L., J. B. Hibbs, J. R. Perfect, and D. T. Durack. 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85:264.
40. Closs, E. I., J.-S. Scheld, M. Sharafi, and U. Förstermann. 2000. Substrate supply for nitric oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol. Pharmacol. 57:68.
41. Hibbs, J. B., Z. Vavrin, and R. R. Taintor. 1987. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550.
42. Fafournoux, P., A. Bruhat, and C. Jousse. 2000. Amino acid regulation of gene expression. Biochem. J. 351:1.
43. Wang, X., L. E. Campbell, C. M. Miller, and C. G. Proud. 1998. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334:261.
44. Fehlbaum, P., M. Rao, M. Zasloff, and G. M. Anderson. 2000. An essential amino acid induces epithelial β-defensin expression. Proc. Natl. Acad. Sci. USA 97:12723.
45. Chiarugi, A., E. Rovida, P. D. Sbarba, and F. Moroni. 2003. Tryptophan availability selectively limits NO synthase induction in macrophages. J. Leukocyte Biol. 73:172.
46. Lee, J., H. Ryu, R. J. Ferrante, S. M. Morris, and R. R. Ratan. 2003. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. USA 100:4843.
47. Presta, A., U. Siddhanta, C. Wu, N. Sennequier, L. Huang, H. M. Abu-Soud, S. Erzurum, and D. J. Stuehr. 1998. Comparative functioning of dihydro- and tetrahydrobiopterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry 37:298.
48. Panda, K., R. J. Rosenfeld, S. Ghosh, A. L. Meade, E. D. Getzoff. and D. J. Stuehr. 2002. Distinct dimer interaction and regulation in nitric oxide synthase types I, II and III. J. Biol. Chem. 277:31020.
49. Klatt, P., K. Schmidt, D. Lehner, O. Glatter, H.-P. Bächinger, and B. Mayer. 1995. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J. 14:3687.
50. Camargo, E. P., J. A. Coelho, G. Morales, and E. N. Figueiredo. 1978. Trypanosoma spp., Leishmania spp., and Leptospira spp.: enzymes of ornithine-arginine metabolism. Exp. Parasitol. 45:141.
51. Gobert, A. P., D. J. McGee, M. Akhtar, G. L. Mendz, J. C. Newton. Y. Cheng, H. L. T. Mobley, and K. T. Wilson. 2001. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. USA 98:13844.
52. Eckmann, L., F. Laurent, T. D. Langford, M. L. Hetsko, J. R. Smith, M. F. Kagnoff, and F. D. Gillin. 2000. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J. Immunol. 164:1478.
53. Chang, C.-I., J. C. Liao, and L. Kuo. 2001. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide mediated tumor cytotoxicity. Cancer Res. 61:1100.
54. Leu, S. Y., and S. R. Wang. 1992. Clinical significance of arginase in colorectal cancer. Cancer 70:733.
55. ω -hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res. 60:3305.